+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A study of the copper T intrauterine contraceptive device (TCu 200) in nulliparous women



A study of the copper T intrauterine contraceptive device (TCu 200) in nulliparous women



American Journal of Obstetrics and Gynecology 116(8): 1092-1096



A study of the effectiveness and complications associated with the Model 200 copper T intrauterine device in 471 nulliparous women ranging in age from 14-33 years is reported, including 6044 woman-months of device use. 128 of the patients had had 1 or more previous abortions. This T-shaped device is made of polyethylene impregnated with barium sulfate, wound with .2 mm diameter copper wire providing a copper surface area of 200 square mm, and is inserted easily without anesthesia and with minimal pain. Continuation and failure rates were calculated for the first 12 months of use by life-table analysis. The overall continuation rate of device use was 74.2 per 100 women, the expulsion rate was 5.4, removal rate for bleeding or pain was 10.7, and pregnancy failure occurred at a rate of 1.7 per 100 women per year. These discontinuation event rates are lower than those reported for other IUDs in nulliparous women and comparable to IUD rates in multiparas. In the past, other IUD designs have been very unsatisfactory in nulliparas because of high expulsion and removal rates, but this study indicates that the TCu 200 IUD model is well accepted by nulliparas with good safety and effectiveness, and provides a promising and highly desired contraceptive alternative to oral contraception for young women.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 042124895

Download citation: RISBibTeXText

PMID: 4721138

DOI: 10.1016/0002-9378(73)90942-3


Related references

Experience with three different models of the Copper T intrauterine contraceptive device in nulliparous women. American Journal of Obstetrics and Gynecology 119(3): 414-417, 1974

A three-year study of the copper-7 minigravigard intrauterine contraceptive device in nulliparous women. Journal of the Medical Association of Thailand 71(6): 294-297, 1988

Pain response following insertion of a Gravigard (Copper-7) intrauterine contraceptive device in nulliparous women. International Journal of Fertility 26(1): 53-56, 1981

Effect of age on pelvic inflammatory disease in nulliparous women using a copper 7 intrauterine contraceptive device. British Medical Journal 281(6233): 114, 1980

Copper intrauterine device use by nulliparous women: review of side effects. Contraception 75(6 Suppl): S8, 2007

Experience with 3 different models of the copper t intra uterine contraceptive device in nulliparous women. American Journal of Obstetrics & Gynecology 119(3): 414-417, 1974

The use of a modified copper intrauterine device in nulliparous women with small uterine axial length. Journal of Reproductive Medicine 25(4): 183-186, 1980

Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease. Contraception 78(4): 315-318, 2008

The threadless copper intrauterine contraceptive device: analysis of the first 150 women-years. British Journal of Obstetrics and Gynaecology 103(6): 574-576, 1996

The localization and concentration of copper in the fallopian tube in women with or without an intrauterine contraceptive device. Acta Obstetricia et Gynecologica Scandinavica 73(3): 195-199, 1994

Serum immunoglobulin levels in women fitted with a copper T intrauterine contraceptive device. Wiener Klinische Wochenschrift 87(20): 681-683, 1975

Intrauterine device quo vadis? Why intrauterine device use should be revisited particularly in nulliparous women?. Open Access Journal of Contraception 6: 1-12, 2015

Motivation and experience of nulliparous women using intrauterine contraceptive devices. Journal of Obstetrics and Gynaecology Canada 32(4): 335-338, 2010

Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate. Contraception 88(6): 737-743, 2013

Intrauterine mepivacaine instillation for pain relief during intrauterine device insertion in nulliparous women: a double-blind, randomized, controlled trial. Contraception 99(6): 335-339, 2019